13F · Intellia Therapeutics Inc
NTLA institutional ownership and 13F activity
Track NTLA institutional ownership through SEC 13F filings, including top shareholders, reported positions, portfolio weights, buys, sells, and quarterly holding trends.
Historical filing data, not live positions.Snapshot generated Sep 12, 2026 from SEC EDGAR 13F-HR information tables. 13F reports can arrive up to 45 days after quarter-end and omit many asset types.
01
NTLA Institutional Ownership Snapshot
See how many institutions reported NTLA, their combined market value, ownership concentration, and latest position changes.
Active holders1
Reported value$285.5M
Top 5 concentration100.0%
New holders0
Reduced holders0
Exited holders0
02
NTLA Ownership Takeaways
Highlights from the latest NTLA 13F filings, including the largest holder, biggest increase, largest reduction, and ownership concentration.
03
Who Owns NTLA? Institutional Holders
Compare 1 current and exited NTLA positions by manager, shares, reported market value, portfolio weight, and quarter-over-quarter change.
| Manager | Shares | Reported value | Portfolio weight | Share change | Status |
|---|---|---|---|---|---|
| Cathie Wood / ARK InvestJun 30, 2026 · CIK 0001697748 | 16.9M | $285.5M | 1.85% | +16.3% | Increased |
04
NTLA Institutional Buying and Selling
See which institutions opened, increased, reduced, or exited NTLA positions compared with their previous 13F filing.
New 0
No holders in this category.
Increased 1
ARK Invest$285.5M · +16.3%
Reduced 0
No holders in this category.
Exited 0
No holders in this category.
05
Types of Institutional Holders
Compare concentrated funds, diversified managers, and broad portfolios that reported NTLA. Categories are based on portfolio breadth, not SEC classifications.
Broad portfolios1
tracked holders06
NTLA Institutional Ownership by Quarter
Follow reported NTLA holders, shares, and market value across recent quarters. The institutions included may vary by filing period.
Q2 20261 holders
$285.5M16.9M sharesQ1 20261 holders
$186M14.5M sharesQ4 20251 holders
$127.7M14.2M sharesQ3 20251 holders
$205.8M11.9M sharesQ2 20251 holders
$122.1M13M shares| Quarter | Holders | Reported value | Shares | New | Exits |
|---|---|---|---|---|---|
| Jun 30, 2026 | 1 | $285.5M | 16.9M | 0 | 0 |
| Mar 31, 2026 | 1 | $186M | 14.5M | 0 | 0 |
| Dec 31, 2025 | 1 | $127.7M | 14.2M | 0 | 0 |
| Sep 30, 2025 | 1 | $205.8M | 11.9M | 0 | 0 |
| Jun 30, 2025 | 1 | $122.1M | 13M | 0 | 0 |
07
Stocks Held by Similar Institutions
Discover other stocks reported by institutions that also hold NTLA, and compare holder counts, market value, and concentration.
8 tracked rowsGOOGLALPHABET INC · $32.6B6 tracked rowsGOOGALPHABET INC · $11B9 tracked rowsAMZNAMAZON COM INC · $9.8B7 tracked rowsTSMTaiwan Semiconductor Manufacturing Company Ltd · $8.2B9 tracked rowsMETAMETA PLATFORMS INC · $5.1B7 tracked rowsNVDANVIDIA Corp · $4.5B6 tracked rowsMSFTMICROSOFT CORP · $4.1B6 tracked rowsAMDAdvanced Micro Devices Inc · $1.4B
08
Common Questions About NTLA
Who is the largest tracked institutional holder of NTLA?
ARK Invest is the largest active holder in the current NTLA sample, reporting $285.5M. The NTLA holder table ranks every matched manager.
Which institution increased its NTLA position the most?
ARK Invest recorded the largest increase or new position by current reported value at $285.5M. Its row appears in the NTLA change section.
Which institution reduced or exited NTLA most significantly?
No tracked institution reported a reduction or exit in NTLA during the current cycle.
Did new holders enter or existing holders exit NTLA?
0 new holders entered and 0 holders fully exited in the current filing cycle. Counts reflect the SEC 13F filings currently included on BasisPilot.
How concentrated is tracked ownership in NTLA?
The five largest tracked holders account for 100.0% of aggregate reported NTLA value. This is concentration within the tracked sample, not the entire market.
How has tracked ownership in NTLA changed across four quarters?
From the oldest comparable quarter to the latest, aggregate reported NTLA value among tracked managers increased by 133.8%. Manager coverage can vary by quarter.
What company evidence should be checked alongside NTLA's 13F changes?
Review Intellia Therapeutics Inc's latest earnings, SEC filings, guidance, capital allocation, and material company events. Delayed 13F data alone cannot confirm that a manager still holds the same position today.
09
Sources and Methodology
Source: SEC EDGAR Form 13F-HR information tables. Positions are grouped by investment manager and ticker, then compared with the prior available filing. 13F data is delayed, historical, and does not represent a manager's complete or current portfolio.